2024 Election Year Stocks: Uncover Hidden Gems!

In the lead-up to the pivotal 2024 election year, we're excited to present our comprehensive report, "Election Year Investment Gems: Stock Poised To Takeoff In 2024," brimming with insights and opportunities you won't want to miss.

Secure your copy now by clicking this link.

Harriet Booker Biography and Net Worth

COO of Option Care Health

Harriet Booker brings vast leadership experience in the home infusion industry to Option Care Health. For over two decades, she has worked in executive leadership roles for BioScrip, Option Care, its predecessor company Walgreens-Option Care, Coram/CVS Specialty Infusion Services, Coram Specialty Infusion, and Apria Healthcare. Most recently, she served as Senior Vice President & Chief Operating Officer at BioScrip. Previously, she served as Interim Senior Vice President, Revenue Cycle Management for Option Care. Prior to that, and for seven years, Ms. Booker successfully led Sales and Marketing for Coram/CVS Specialty Infusion Services, including roles as Executive Vice President of Sales and Chief Commercial Officer, among others. Booker served in leadership roles for Option Care (and Walgreens-Option Care) from 2002-2008 including Director of Sales Operations, Vice President of Managed Care Sales, and Vice President of Sales and Marketing. Her home infusion experience also includes pertinent work in patient admissions, revenue cycle management, financial planning, forecasting, pricing, and contracting.

Booker holds bachelor’s degrees in English and Political Science from the University of Colorado Boulder as well as an MBA in Finance and Marketing from Tulane University.

What is Harriet Booker's net worth?: The estimated net worth of Harriet Booker is at least $1.87 million as of June 6th, 2022. Ms. Booker owns 80,760 shares of Option Care Health stock worth more than $1,867,979 as of November 23rd. This net worth evaluation does not reflect any other assets that Ms. Booker may own. Learn More about Harriet Booker's net worth.
How do I contact Harriet Booker?: The corporate mailing address for Ms. Booker and other Option Care Health executives is 3000 Lakeside Dr. Suite 300N, Bannockburn IL, 60015. Option Care Health can also be reached via phone at (312) 940-2443 and via email at [email protected]. Learn More on Harriet Booker's contact information.
Has Harriet Booker been buying or selling shares of Option Care Health?: Harriet Booker has not been actively trading shares of Option Care Health in the last ninety days. Most recently, Harriet Booker sold 6,000 shares of the business's stock in a transaction on Monday, June 6th. The shares were sold at an average price of $30.25, for a transaction totalling $181,500.00. Following the completion of the sale, the chief operating officer now directly owns 80,760 shares of the company's stock, valued at $2,442,990. Learn More on Harriet Booker's trading history.
Who are Option Care Health's active insiders?: Option Care Health's insider roster includes Michael Bavaro (Insider), Elizabeth Betten (Director), Elizabeth Bierbower (Director), Harriet Booker (COO), Harry Jansen Kraemer (Director), R. Pate (Director), John Rademacher (CEO), Michael Shapiro (CFO), Collin Smyser (Insider), and Timothy Sullivan (Director). Learn More on Option Care Health's active insiders.
Are insiders buying or selling shares of Option Care Health?: In the last year, Option Care Health insiders bought shares 2 times. They purchased a total of 78,000 shares worth more than $2,073,470.00. In the last year, insiders at the sold shares 2 times. They sold a total of 70,748 shares worth more than $2,196,304.94. The most recent insider tranaction occured on November, 8th when Director Harry M Jansen Kraemer Jr bought 43,000 shares worth more than $969,220.00. Insiders at Option Care Health own 0.6% of the company. Learn More about insider trades at Option Care Health.
Information on this page was last updated on 11/8/2024.

Harriet Booker Insider Trading History at Option Care Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/6/2022	Sell	6,000	$30.25	$181,500.00	80,760
5/6/2022	Sell	6,000	$28.81	$172,860.00	81,511
4/6/2022	Sell	6,000	$27.18	$163,080.00	81,511
3/7/2022	Sell	6,000	$26.12	$156,720.00
2/7/2022	Sell	6,000	$23.61	$141,660.00
1/6/2022	Sell	6,000	$26.29	$157,740.00
12/6/2021	Sell	6,000	$24.81	$148,860.00
11/8/2021	Sell	6,000	$27.93	$167,580.00

Harriet Booker Buying and Selling Activity at Option Care Health

Option Care Health Company Overview

Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. It also offers treatments to manage the progression of neurological disorders, such as multiple sclerosis, duchenne muscular dystrophy, and other neurological disorder; infusion therapies for bleeding disorders, such as hemophilia and von Willebrand diseases; therapies for women with high-risk pregnancies; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications, as well as nursing services. The company markets its services through patient referrals, including physicians, hospital discharge planners, hospital personnel, health maintenance organizations, and preferred provider organizations. Option Care Health, Inc. is headquartered in Bannockburn, Illinois.

Today's Range

Now: $23.13

$22.51

$23.24

50 Day Range

MA: $27.62

$21.74

$31.90

2 Week Range

Now: $23.13

$21.39

$34.63

Volume

1,638,831 shs

Average Volume

1,540,403 shs

Market Capitalization

$3.94 billion

P/E Ratio

19.44

Dividend Yield

N/A

Beta

1.32